Literature DB >> 170213

Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.

F Lesnik, L J Ross.   

Abstract

Immunity against Marek's disease was conferred by the use of non-infectious materials extracted with non-ionic detergents from cells infected with the attenuated strain of Marek's disease virus (MDV). Antibody-free Rhode Island Red chicks were inoculated at 1 week of age with cell extracts emulsified in Freund's complete adjuvant and were given a second inoculation 1 week later without adjuvant. Protection against natural infection was obtained in groups inoculated with both soluble (not sedimented at 100,000 times g/2h) and insoluble antigens present in Nonidet P40 (NP40) extract, but only with the insoluble fraction of deoxycholate extract. The results suggest that the immunizing antigens can be partially solubilized with 0.5% NP40 and that the growth and spread of MDV are reduced in immunized chickens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170213     DOI: 10.1002/ijc.2910160117

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Comparative effects of host and viral factors on early pathogenesis of Marek's disease.

Authors:  J Fabricant; M Ianconescu; B W Calnek
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.

Authors:  K K Murthy; B W Calnek
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen.

Authors:  L F Velicer; D R Yager; J L Clark
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

Review 4.  Historical background.

Authors:  M A Epstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

Review 6.  The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention.

Authors:  P M Biggs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

7.  Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys.

Authors:  A P Wyn-Jones; O R Kaaden
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.